| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ib-meca | adenosine a3 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Dental Plaque[MeSHID:D003773] Malignant Neoplasms[MeSHID:D009369] Psoriasis[MeSHID:D011565] Senile Plaques[MeSHID:D058225] Rheumatoid Arthritis[MeSHID:D001172] |
2.12 | phase 3 | unknown |
| ib-meca | adenosine a3 receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Dental Plaque[MeSHID:D003773] Malignant Neoplasms[MeSHID:D009369] Psoriasis[MeSHID:D011565] Senile Plaques[MeSHID:D058225] Rheumatoid Arthritis[MeSHID:D001172] |
2.12 | phase 3 | agonist |
| click here to return to the previous page | ||||||||